MMedication Read More FDA Approves Once Daily Parkinson’s Pill for Treating SymptomsOctober 3, 2026 In the U.S., over one million people live with Parkinson’s. While there are symptom-treating medications that help tame…
MMedication Read More GLP-1 use skyrocketed 24x in a key demographicOctober 3, 2026 This year, the number of US adults on a GLP-1 medication for weight loss reached an astonishing 11%…
MMedication Read More Govt revises essential drug list, adds specialised drugs and medical devices | Patna NewsOctober 3, 2026 Patna: The health department has revised its Essential Drug List (EDL), adding specialised medicines and medical devices for…
MMedication Read More Over 112,000 Bottles of Popular Pain Reliever Recalled Nationwide After Consumer ComplaintsOctober 3, 2026 From fever to headache relief, there’s a good chance you’ve reached for acetaminophen at some point. Most people…
MMedication Read More TOI Healing India Forum 2026: Meet the jury shaping India’s wellness conversationOctober 3, 2026 Meet the jury for TOI Healing India Forum 2026 As wellness becomes an increasingly visible part of everyday…
MMedication Read More Why sharing your pills can harm your health, Gauteng Health warnsOctober 3, 2026 Gauteng health officials urged residents not to share prescribed medicines, even when symptoms look alike. The Gauteng Department…
MMedication Read More Edmontonians encouraged to safely dispose of unused drugs – CTV NewsOctober 3, 2026 Edmontonians encouraged to safely dispose of unused drugs CTV NewsIn plain sight: Danger lurks for teens in the home…
MMedication Read More Daniel Drucker, the Canadian scientist behind Ozempic on why he never gave upOctober 3, 2026 The decades-long journey to discovering the weight-loss drug that changed the world took an unlikely turn in an…
MMedication Read More FDA cancels Pune Cipla facility’s drug sale and distribution licences | Mumbai NewsOctober 3, 2026 Maharashtra Food and Drug Administration has cancelled the drug sale and distribution licences of Cipla Pharma’s warehouse in…
MMedication Read More Lilly’s Jaypirca (pirtobrutinib), the first-and-only approved non-covalent BTK inhibitor, receives expanded indication from U.S. FDA for certain patients with previously untreated CLL/SLLOctober 3, 2026 INDIANAPOLIS, Oct. 2, 2026 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food…
MMedication Read More Blood Pressure Medication Recall: Over 25,000 Bottles Affected in 2026October 2, 2026 Share on PinterestThe FDA initiated a second recall of its 25 mg chlorthalidone tablets this year, bringing the…
MMedication Read More New weight-loss drug targets belly fat and can give ‘flatter stomach’ in weeksOctober 2, 2026 Could a new drug that makes fat cells self-destruct be the next big GLP-1? CBL-514 targets fat cells,…